Skip to main content

Table 2 Prognostic value of AHNAK for overall survival in triple-negative breast cancer patients by Univariate and Multivariate analyses

From: AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

Variables

Univariate analysis

Multivariate analysis

RR

95% IC

P value

RR

95% IC

P value

Age (<50 vs. ≥50 years)

1.137

0.748–1.728

0.548

-

-

-

Menopause (Yes vs. No)

1.069

0.701–1.630

0.758

-

-

-

BMI (<25 vs. ≥ 25)

1.057

0.654–1.710

0.820

-

-

-

Histological grade(G1 + G2 vs. G3)

1.626

1.064–2.485

0.025*

1.272

0.821–1.970

0.282

TNM Staging(I + II vs. III + IV)

3.340

2.199–5.073

<0.001*

2.834

1.827–4.397

<0.001

Ahnak(low vs. high)

2.094

1.366–3.209

0.001*

1.641

1.053–2.558

0.029

  1. *Statistically significant prognostic factor identified by Univariate/Multivariate analysis